Elinzanetant and Abemaciclib: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Abemaciclib
Elinzanetant
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Abemaciclib (Verzenio) is a cancer medicine that your body clears using a liver enzyme called CYP3A4. Elinzanetant (Lynkuet) can gently slow that same enzyme down. When the enzyme works slower, your body may clear abemaciclib less well, so more of it can build up in your blood.
More abemaciclib in your system can mean stronger side effects, like diarrhea, low blood counts, tiredness, or nausea. This concern is mostly based on how the drugs work rather than a lot of real-world reports, but abemaciclib is a drug where even small changes matter. The good news: your cancer team can manage this. Talk with your oncologist or pharmacist before taking both together.
Mechanism: Elinzanetant is a weak CYP3A4 inhibitor; abemaciclib is a CYP3A4 substrate. Reduced metabolism may increase abemaciclib exposure (AUC/Cmax) and the risk of dose-related toxicity.
- Direction: Increased abemaciclib effect and adverse reactions (myelosuppression, diarrhea, hepatotoxicity, fatigue, ILD).
- Evidence: Theoretical; based on PK mechanism, not clinical outcome data.
- Onset: Unspecified.
- Severity: Major, given abemaciclib's narrow margin where small concentration changes may drive serious reactions.
- Management: Avoid concomitant use where feasible; if combined, individualize abemaciclib dosing and increase monitoring (CBC, LFTs, GI tolerability) per oncology guidance.
What happens
Increased CYP3A4 substrate with NTI exposure and an increased CYP3A4 substrate with NTI-related adverse reactions
Interaction Deep Dive
When taken together, elinzanetant (a weak inhibitor of CYP3A4) raises the exposure of CYP3A4 substrates, which can heighten the likelihood of adverse reactions associated with those substrates. For this reason, elinzanetant should not be combined with CYP3A4 substrates in cases where even small shifts in concentration could trigger serious adverse reactions1.
Why it happens (mechanism)
Inhibition of CYP3A4-substrate metabolism by elinzanetant
How to manage this interaction
What your care team may do:
- Consider avoiding the combination when possible, since abemaciclib is sensitive to even small changes in blood levels.
- If both are needed, your abemaciclib dose may be adjusted and individualized by your care team.
- Watch you more closely with lab tests (blood counts, liver function) and check in about side effects like diarrhea, fatigue, or nausea.
What you should do: Keep taking both exactly as prescribed unless your team tells you otherwise. Before starting elinzanetant, let your oncologist and pharmacist know you take abemaciclib, and report any new or worsening side effects promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) A drug interaction study demonstrated that giving elinzanetant together with midazolam raised the Cmax of midazolam (a sensitive CYP3A4 substrate) by 1.5-fold and its AUC by 1.8-fold 1.
Common questions
Can I take Elinzanetant and Abemaciclib together?
Elinzanetant may raise abemaciclib levels and side effects, so this combination is often best avoided; if used together, your oncology team will individualize the dose and monitor you closely. Don't change anything on your own, check with your oncologist or pharmacist first. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Elinzanetant and Abemaciclib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Elinzanetant and Abemaciclib interaction managed?
What your care team may do: Consider avoiding the combination when possible, since abemaciclib is sensitive to even small changes in blood levels. If both are needed, your abemaciclib dose may be adjusted and individualized by your care team. Watch you more closely with lab tests (blood counts, liver function) and check in about side effects like diarrhea, fatigue, or nausea. What you should do: K… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Elinzanetant or Abemaciclib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: LYNKUET® oral capsules, elinzanetant oral capsules. Bayer HealthCare Pharmaceuticals Inc (per Manufacturer), Whippany, NJ, 2025. DailyMed
Keep reading about Abemaciclib
Keep reading about Elinzanetant
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist